After     the     first     group     study     (2004, University      of      Witten/Herdecke),      the efficacy     of     SIPARI®     could     now     be proven       again       in       a       Randomized Controlled   Trial   (in   cooperation   with   the University    Hospital    of    RWTH    Aachen). The     results     were     just     published     in Journal of Neurology .

evidence-based music-supported therapy for

chronic aphasia patients

SIPARI®  

was  

developed  

by  

Dr.  

Jungblut  

and  

first  

tried  

and  

tested

in   

cooperation   

with   

the   

Medical   

Faculty   

of   

the   

University   

of

Witten-Herdecke, Germany.

In  

2010  

the  

Cochrane  

Review  

“Music  

therapy  

for  

acquired  

brain

injury”   

(

download

)   

included   

a   

controlled   

SIPARI®   

group-study

(mean    

duration    

of    

aphasia:    

11.5    

years)

.    

In    

international

comparison,  

this  

was  

the  

only  

study,  

which  

provided  

evidence  

that

this  

specifically  

targeted  

music-supported  

treatment  

significantly

improved  

the  

speech  

profile  

of  

people  

with  

chronic  

aphasia.

(Bradt  

J,

Magee  

WL,  

Dileo  

C,  

Wheeler  

BL,  

McGilloway  

E.  

Music  

therapy  

for  

acquired  

brain

injury.  

Cochrane  

Database  

of  

Systematic  

Reviews  

2010,  

Issue  

7.  

Art.  

No.:  

CD006787.

DOI: 10.1002/14651858. CD006787.pub2.)

The  

Cochrane  

Collaboration,  

editor  

of  

the  

Cochrane  

Review,  

sets

the    

international    

standard    

for    

independent    

evaluation    

and

assimilation     

of     

scientifically     

proven     

evidence     

as     

a     

Non

Governmental Partner of the World Health Organization (WHO).

The    Interdisciplinary    Institute    for    Music-    and    Speech-Therapy conducts    functional    imaging    studies    in    cooperation    with    the Brain   Imaging   Facility    of   the   Interdisciplinary   Center   for   Clinical Research at the University Hospital Aachen, Germany.

Meanwhile     

further     

single     

case     

studies     

substantiate     

the

extraordinary   

efficacy   

of   

SIPARI®   

in   

the   

treatment   

of   

severely

impaired    

chronic    

aphasia    

patients    

and    

also    

patients    

with

concomitant apraxia of speech.

Due   

to   

the   

increasing   

number   

of   

inquiries   

for   

SIPARI®,   

the

Interdisciplinary    

Institute    

for    

Music-    

and    

Speech-Therapy    

will

provide  

training  

courses  

for  

therapists  

(duration  

2  

days  

each)  

in  

San

Diego, CA, on a regular basis.

The  

trainings  

will  

be  

conducted  

by  

Dr.  

Jungblut.  

You  

can  

contact  

us

via Email

Interdisciplinary Institute for

Music- and Speech-Therapy

Dr. rer. medic. Monika Jungblut

Am Lipkamp 14

47269 Duisburg

Germany

tel.: +49 203 711319